All
After a dry spell, metastatic prostate cancer sees dramatic improvement with new therapies
Two new drugs approved, one pulled from the pipeline
Cancer screening rates low
A 'gutsy' phase 3 clinical trial in colorectal cancer
An Introduction to Multiple Myeloma
An introduction to multiple myeloma.
How Is Multiple Myeloma Diagnosed?
Learn how multiple myeloma is diagnosed.
How is Multiple Myeloma Staged?
Learn how multiple myeloma is staged.
A Guide to Multiple Myeloma Treatment Options
Learn about treatment options for multiple myeloma.
Side Effects & Complications of Multiple Myeloma
The potential side effects and complications of multiple myeloma.
Survivor Story: Fear of Multiple Myeloma Recurrence
A survivor's story of overcoming fear of myeloma recurrence.
Survivor Story: Living with Multiple Myeloma
A survivor's story of living with multiple myeloma.
Questions to Ask Your Medical Team about Multiple Myeloma
Questions to ask your medical team about multiple myeloma.
A call for more pancreatic cancer research
Not as I Pictured: My Journey Through Hodgkin Lymphoma
An introduction to cancer: From a father and his daughter
The cushion of silence
Cancer apps
Emerging treatment option for myeloma presented at hematology meeting
GA101 Could Upstage Rituxan in Lymphoma
GA101 could be the next step for patients who relapse on Rituxan (rituximab), a current standard of therapy.
Investigational Drug Shows Benefit in CLL
In an early-phase study, PCI-32765, a BTK inhibitor, was shown to work against CLL, a type of non-Hodgkin lymphoma.
No Need for Maintenance Rituxan in Asymptomatic Follicular Lymphoma
Patients who are not suffering from symptoms of nonbulky follicular lymphoma are better off waiting until symptoms occur before beginning chemotherapy instead of undergoing maintenance Rituxan.
Ponatinib Overcomes Tricky Mutation in CML
A novel drug called ponatinib that targets the BCR-ABL mutation overcomes a mutation that has been resistant to all previous approved therapies.
Different Dosing Schedule May Revive Withdrawn Drug
A drug removed from the market last year to treat acute myeloid leukemia may have a second life.
Lymphoma Drug Adcetris Tested in Newly Diagnosed Patients
With the approval of Adcetris (brentuximab vedotin) for relapsed Hodgkin lymphoma, researchers are now examining whether the drug will help newly diagnosed patients.
The big news from the American Society of Hematology
Dealing with the side effects of side effects
Studies highlight progress in lymphoma, pose more questions
Cancer and Christmas
You have truly experienced the love that this season represents.
Living with cancer
